Amphastar Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Amphastar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.78M, a 18.8% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $22.4M, a 14.4% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20.2M, a 13.3% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.9M, a 4.43% decline from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $18.7M, a 8.84% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.2M +$2.38M +13.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $17.9M -$827K -4.43% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $18.7M -$1.81M -8.84% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $20.5M +$3.2M +18.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $17.3M +$615K +3.69% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 $16.7M -$407K -2.38% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 $17.1M +$1.96M +13% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $15.1M +$2.31M +18% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 $12.8M +$3.54M +38.1% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $9.28M +$2.25M +31.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $7.04M -$390K -5.25% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $7.43M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.